Table 1: Comparison of General Data Between the Two Periods
|
1990-1997 (n =748) |
2003-2005 (n=311) |
p Value |
|
|
Age (Median; range) |
67 (32-91) |
68 (33-95) |
ns |
|
| Sex |
| Male |
703 (94%) |
279 (89.7%) |
p 0.014 |
| Female |
45 (6%) |
32 (10.3%) |
|
|
| Histology |
| Squamous cell Ca |
384 (51.3%) |
101 (32.5%) |
p<0.001 |
| Adenocarcinoma |
232 (31%) |
159 (51.1%) |
p<0.001 |
| L. Cell/Undifferentiated |
106 (14.2%) |
41 (13.2%) |
ns |
| Unknown |
26 (3.5%) |
10 (3.2%) |
ns |
|
| Differentiation |
| Grade I |
16 (2.1%) |
9 (2.9%) |
ns |
| Grade II |
116 (15.5%) |
38 (12.2%) |
ns |
| Grade III |
233 (31.1%) |
135 (43.4%) |
p<0.001 |
| Unknown |
383 (51.2%) |
129(41.5%) |
p 0.004 |
|
| Stage |
| Ia |
43 (5.7%) |
31 (10%) |
ns |
| Ib |
70 (9.4%) |
21 (6.8%) |
|
| IIa |
0 |
8 (2.6%) |
|
| IIb |
42 (5.6%) |
18 (5.8%) |
|
| IIIa |
44 (5.9%) |
28 (9%) |
|
| IIIb |
155 (20.7%) |
86 (27.7%) |
|
| IV |
276 (36.9%) |
116 (37.3%) |
|
| Unknown |
118 (15.8%) |
3 (1%) |
|
|
| Treatment |
| Supportive care |
332 (44.4%) |
73 (23.5%) |
p<0.001 |
| Surgery |
167 (22.3%) |
63 (20.2%) |
ns |
| Chemotherapy |
235 (31.4%) |
186 (59.8%) |
p<0.001 |
| Radiotherapy |
151 (20.2%) |
120 (38.7%) |
p<0.001 |